Circuit Training With and Without Upper and Lower Limb Resistance Training in Post-CABG Patients
Effects of Circuit Training With and Without Upper and Lower Limb Resistance Training on Paroxysmal Nocturnal Dyspnea, Functional Capacity and Endurance in Post-CABG Patients
This study aims to evaluate the contrasting effects of circuit training with and without upper and lower limb resistance training on paroxysmal nocturnal dyspnea, functional capacity and endurance on post-CABG patients.
Registry Overview
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Recruitment status
completed
Actual enrollment (reported)
60 participants
Study completion date
December 20, 2025
Actual (reported)
Listed locations
1 countries · 1 sites
Trial Relationships
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Related Scientific Literature
Loading related publications...
Study Timeline
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
The mMRC Dyspnea Scale is a validated tool to assess the severity of dyspnea among the patients with pulmonary complications. This scale was utilized to quantify the symptoms of paroxysmal nocturnal dyspnea among the participants in the study, offering an insight to the effectiveness of exercise interventions on the respiratory symptoms
First day
1-Repetition Maximum (1-RM)
1-RM is a useful tool in the studies in the studies evaluating the effectiveness of strength training such as those addressing upper and lower limb resistance training. This test specifies the maximum weight that a subject can lift in a single repetition, providing a precise, quantitative baseline evaluation of dynamic strength. It can be used as a solid baseline for tracking and comparing strength changes during intervention. Thus, 1-RM is a practical and objective tool in rehabilitation research. It allows the researchers to analyze the effectiveness of certain treatments and monitor functional changes over the course of treatment or regimen.
First day
Modified Borg Scale (BORG CR-10):
Modified Borg Dyspnea Scale is a highly validated subjective tool, to assess rate of perceived exertion during exercise to monitor exercise intensity and tailor to individual patient in cardiac rehabilitation settings. It is safe and cost-effective. It has a rating of 0-10 with zero representing (no breathlessness) and 10 (maximal exertion). It is a subjective measure of how hard the body is pushing against exertion during exercise. Specially designed for the assessment of cardiac endurance
First day
Study Arms (2)
Group A: Circuit Training with upper and lower limb Resistance Training
EXPERIMENTAL
A series of exercises in a circuit format with Resistance Training: for upper and lower limbs (30-40% of 1-RM)
Other: Circuit Training with upper and lower limb Resistance Training
Group B: Circuit Training only
EXPERIMENTAL
Exercises in circuit format (30-40 minutes)
Other: Circuit Training Exercises
Interventions
Circuit Training with upper and lower limb Resistance TrainingOther
A series of exercises in a circuit format, with 1 minute of exercise followed by 30 seconds of rest. The circuit was repeated 2-3 times, with a 2-minute break between circuits along with upper and lower limb Resistance exercises (30-40% of 1-RM) using weights and therapeutic bands
Group A: Circuit Training with upper and lower limb Resistance Training
Circuit Training ExercisesOther
A series of exercises in a circuit format, with 1 minute of exercise followed by 30 seconds of rest. The circuit was repeated 2-3 times, with a 2-minute break between circuits.
Eligibility Criteria
Age35 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
You may qualify if:
Adult CABG surgery candidates aged between 35 and 65 years who underwent uncomplicated CABG surgery within past 3-6 months.
DyspneaRespiration DisordersRespiratory Tract DiseasesHeart FailureHeart DiseasesCardiovascular DiseasesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms
Intervention Hierarchy (Ancestors)
Physical Conditioning, Human
Study Officials
Qurat ul Ain, MS
Riphah International University
PRINCIPAL INVESTIGATOR
Enrollment
60 participants (actual enrollment reported by the registry).
Study Design
Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR
Study Record Dates
First Submitted
March 16, 2026
First Posted
March 20, 2026
Study Start
July 5, 2025
Actual (reported)
6-Minute Walk Test 6-MWT:
It is a reliable tool for assessing functional capacity among the patient population that present with underlying cardiovascular and pulmonary conditions. We used this tool in the assessment of functional capacity among the patients that participated in the study. This test specifically measures the distance covered in 6 minutes. In this test the participant walks along a flat straight pathway (usually 30-meter indoor corridors) in six minutes at their own pace. The maximum distance covered in 6 minutes documented the functional capacity among the participants under study.
First day
Incremental Shuttle Walk Test (ISWT)
Incremental Shuttle Walk Test (ISWT) is a highly reliable and valid tool for the assessment of cardiac endurance as a distinct outcome separately from overall functional capacity. It measures cardiac endurance under progressively increasing workloads within the safe limits. We used this tool to assess the cardiopulmonary endurance and baseline functional status in CABG population and to measure the improvements post-intervention outcomes. The test is safe, cost-effective and convenient to implement in all the clinical settings requiring little equipment and simultaneously assesses physiological responses such as heart-rate HR, oxygen saturation SPO2, and blood pressure in accordance with the subjective effort.
First day
Group B: Circuit Training only
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Clinically stable cardiac status and approval for participation in phase-II cardiac rehabilitation from the cardiac surgeon.
Patients that presented with the symptoms of mild to moderate levels of paroxysmal nocturnal dyspnea (PND). (38)
Willingness and availability to participate in the phase-II cardiac rehabilitation program for the study duration.
Physical ability to perform both upper and lower limb strength training exercise.
Absence of pre-existing severe orthopedic limitations that could interfere with the exercise performance.
You may not qualify if:
Uncontrolled hypertension, cardiac arrhythmias or any unstable cardiovascular complication that was an absolute contraindication to participate in clinical exercise program.
Severe pre-existing pulmonary conditions such as COPD or Asthma that could interfere with exercise capacity.
Severe orthopedic limitations such as arthritis, recent fractures and sternal site infections post-surgery.
Neurological complications, including stroke, severe neuropathy, balance and coordination abnormalities that could impede physical performance.
Cognitive impairments that may possibly affect the ability to understand and follow the exercise protocols.
Participation in some other structured rehabilitation program within the past month.
Contact the study team to confirm eligibility.
Exercise
Motor Activity
Movement
Musculoskeletal Physiological Phenomena
Musculoskeletal and Neural Physiological Phenomena
Primary Completion
August 20, 2025
Actual (reported)
Study Completion
December 20, 2025
Actual (reported)
Last Updated
March 20, 2026
Record last verified: 2026-03
Data Sharing
IPD Sharing
Will not share
Source record
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.